Rule Change for Poliwogg Medical Breakthroughs Index
New York, NY, November 1, 2018 — The Poliwogg Medical Breakthroughs Index Committee today announced the following rule change to be effective for the Q4 2018 reconstitution and going forward, reflected in Sections I (General Description) and IV (Eligibility Criteria and Weighting):
All companies selected for inclusion in PMBI must be principally engaged in the biotechnology sector. Companies instead principally engaged in the pharmaceuticals sector will no longer be eligible for inclusion.
The Poliwogg Medical Breakthroughs IndexSM (TICKER: PMBI) is designed to capture research and development opportunities in the pharmaceutical industry. PMBI consists of small-cap and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Detailed information on the Poliwogg Medical Breakthroughs IndexSM including constituent data, rules and price information is available at www.poliwoggindexes.com. Data is also available through most vendors of financial data.
Index: Poliwogg Medical Breakthroughs IndexSM: TICKER: PMBI
Index: Poliwogg Medical Breakthroughs Total Return IndexSM: TICKER: PMBITR
About S-Network Global Indexes
S-Network Global Indexes, Inc. is a publisher and developer of proprietary and custom indexes. Founded in 1997, S-Network publishes over 200 indexes, which serve as the underlying portfolios for financial products with approximately USD 7 billion in assets under management.S-Network indexes, which are supported by a state-of-the-art technology platform, are known for their transparency and efficiency.
S-Network is a prominent provider of smart beta indexes that incorporate both standard market statistics, as well as unique and highly specialized proprietary data sets derived from non-traditional sources.Smart beta indexes developed by S-Network embrace powerful single-factor models as well as complex multi-factor models that incorporate over 200 discrete factors.All indexes developed by S-Network address and resolve issues such as liquidity, investability and index turnover characteristics.
Poliwogg’s mission is to create innovative financial products that give both institutional and retail investors the widest possible opportunity to hedge and invest in the healthcare economy.
Poliwogg is a financial services company that creates unique tools which give market participants and investors access to specific verticals in the healthcare economy.Poliwogg products categorize investments in a number of different ways: by risk, by sector/subsector, and by particular diseases.These groupings enable more efficient uses of capital within the healthcare sector.
Poliwogg’s management team has extensive experience in finance, healthcare, and investing.It combines that expertise with a passion for increasing and broadening investment in healthcare and for using financial tools to increase efficiency and transparency in healthcare.
S-Network Global Indexes, Inc. is a publisher and developer of proprietary and custom indexes. Founded in 1997, S-Network publishes over 200 indexes, which serve as the underlying portfolios for financial products with approximately USD 7 billion in assets under management. S-Network indexes, which are supported by a state-of-the-art technology platform, are known for their transparency and efficiency. More...
19 Additions and 22 Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution
Dec 19, 2018
13 Additions and 13 Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution
Dec 19, 2018
11 Additions and 51 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution
Dec 13, 2018
S-Network Global Indexes, Inc.
267 Fifth Avenue, Suite 508
Phone: (646) 467-7928